Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Smither John W
Relationship:   Director
City:   Calabasas
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   89,084    

Indirect Shares

   176,353      
Direct Value   $122,234    

Indirect Value

   $1,295,151      
Total Shares   265,437      
Total Value   $1,417,385      


Sienna Biopharmaceuticals, Inc. $0 Arcutis Biotherapeutics, Inc. $104,103 Effector Therapeutics Ord Shs $0 Genelux Corp $18,130 Sienna Biopharmaceuticals, Inc. $0 Arcutis Biotherapeutics, Inc. $104,103 Effector Therapeutics Ord Shs $0 Genelux Corp $18,130
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -78.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Kythera Biopharmaceuticals Inc KYTH Chief Financial Officer 2015-10-01 0 2015-10-01 0    Premium*  
            Sienna Biopharmaceuticals, Inc. SNNA 2019-01-01 46,657 2019-01-01 34,961    Premium*  
            Arcutis Biotherapeutics, Inc. ARQT Chief Financial Officer 2024-02-13 11,365 2024-02-13 141,392    Premium*  
            Effector Therapeutics Ord Shs EFTR Director 2021-08-25 24,142 2021-08-25 0    Premium*  
            Genelux Corp GNLX Director 2023-09-13 6,920 2023-09-11 0    Premium*  
* Premium Members only  

Records found :    99         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ARQT Arcutis Biotherapeutics, ... Chief Financial Officer   •       –      –    2020-12-14 4 AS $30.00 $45,000 D/D (1,500) 25,198 0 %
ARQT Arcutis Biotherapeutics, ... Chief Financial Officer   •       –      –    2021-02-10 4 AS $35.64 $71,280 I/I (2,000) 87,965 0 %
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-04-30 4 S $45.49 $92,845 D/D (2,041) 15,584 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-04-30 4/A S $45.49 $92,845 D/D (2,041) 3,368 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-02-20 4 OE $5.90 $13,275 D/D 2,250 12,450 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-02-20 4 AS $49.75 $111,926 D/D (2,250) 10,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-07-02 4 AS $40.00 $90,000 D/D (2,250) 16,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-07-02 4 OE $8.22 $18,495 D/D 2,250 18,450 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-03-26 4 OE $1.35 $4,050 D/D 3,000 13,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-06-13 4 OE $4.84 $14,520 D/D 3,000 16,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-01-23 4 AS $35.47 $106,940 I/I (3,000) 19,416 0 -
ARQT Arcutis Biotherapeutics, ... Chief Financial Officer   •       –      –    2020-12-14 4 AS $30.00 $112,500 I/I (3,750) 94,965 0 %
ARQT Arcutis Biotherapeutics, ... Chief Financial Officer   •       –      –    2021-02-01 4 AS $35.00 $131,250 I/I (3,750) 89,965 0 %
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2013-05-01 4 AS $24.11 $96,429 D/D (4,000) 0 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2013-05-01 4 OE $1.35 $5,400 D/D 4,000 4,000 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-03-05 4 AS $46.99 $201,980 I/I (4,200) 12,216 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-06-25 4/A S $75.50 $347,300 I/I (4,600) 7,616 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-06-25 4 S $75.50 $347,300 D/D (4,600) 10,984 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-04-29 4/A A $0.00 $0 D/D 5,409 5,409 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-04-29 4 A $0.00 $0 D/D 5,409 17,625 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-09-22 4 S $74.90 $418,766 D/D (5,591) 3,368 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-09-22 4 OE $8.22 $45,958 D/D 5,591 5,483 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2013-06-17 4 AS $26.00 $156,000 D/D (6,000) 0 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2013-06-17 4 OE $1.35 $8,100 D/D 6,000 6,000 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-01-05 4 OE $1.35 $8,392 D/D 6,216 22,416 0 -
  99  Records found
  1   2   3  4      
  Page 3 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us